Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →
logo
Get CLEATUSFree Trial

LIDOCAINE HYDROCHLO

Active
SPE2DP-26-T-4430Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract specifies the procurement of LidoCaine Hydrochloride 2% Mucosal Jelly in single-use prefilled plastic syringes, each containing 220 mg per 11 mL, packaged in boxes of ten units. The product is a sterile topical anesthetic intended for medical use, with a non-extendable shelf life of 36 months and must comply with the Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must meet commercial standards as defined in the procurement document, ensuring each unit is sealed and protected from damage, and shipped in commercial exterior containers that guarantee safe delivery at the lowest cost to the designated destination. The item is identified by NSN 6505-01-707-4169 and NDC 25021-0673-77, supplied by Sagent Pharmaceuticals, Inc., and the unit of issue is one box containing ten syringes. Delivery is required within five days FOB destination, with no variance permitted in quantity, and inspection and acceptance occur at the delivery point. The shipment is directed to USMC facilities in Palmerston, Australia, under a SOFA tariff agreement, with specific transportation and marking instructions governed by DLA procedures. The contract was issued under solicitation SPE2DP-26-T-4430, with a response deadline in August 2026, and is managed by the Department of Defense’s Medical Supply Chain Pharm FSA, with Timothy McCauley listed as the primary point of contact.

General Info

LidoCaine Hydrochloride 2% mucosal jelly in 11 mL syringes, 10 per box, NSN 6505-01-707-4169, DLA delivery to Australia, FOB destination, 36-month shelf life.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325411 - Medicinal and Botanical ManufacturingView NAICS

Place of Performance

US

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-4430.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts
Timothy Mccauley
contact@example.gov
+1 (555) 000-0000

Full Description

Show more
LIDOCAINE HYDROCHLO
LIDOCAINE HYDROCHLORIDE JELLY
IDOCAINE 2% MUCOSAL JELLY IN APPLICATOR 11ML<(>,<)>
220 MG PER 11 ML. BOX OF 10<(>,<)>
SINGLE-USE PREFILLED PLASTIC SYRINGE.
STERILE TOPICAL ANESTHETIC.
UNIT OF ISSUE (1) BOX 10 EACH
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
SPE2DP-26-T-4430
SECTION B
...
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/ ,,,,
SAGENT PHARMACEUTICALS, INC 4RP13 P/N NDC25021-0673-77
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017693912 0001 BX 1.000
NSN/MATERIAL:6505017074169
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:U
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
SPE2DP-26-T-4430
SECTION B
PR: 7017693912 PRLI: 0001 CONT’D
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
BULK BREAK POINT:
MMC191
USMC/US GOVERNMENT-SOFA TARIFF ACT
SUPP BLDG 407 ROBERTSON BARRACKS
M/F:MMC191 MRF-D CLASS IX, I MEF
PALMERSTON 0830
AU
RDD 777 SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
MX0133
USMC/US GOVERNMENT-SOFA TARIFF ACT
SUPP BLDG 407 ROBERTSON BARRACKS
M/F: MX0133 MRF-D LCE, I MEF
PALMERSTON 0830
AU
MARKFOR
MX0133
USMC/US GOVERNMENT-SOFA TARIFF ACT
SUPP BLDG 407 ROBERTSON BARRACKS
M/F: MX0133 MRF-D LCE, I MEF
PALMERSTON 0830
AU
M/F: (TCN) MX013150760013
RDD: 777
PROJ: EMD TP 1
SUPP ADD: M97111 SIG: J
FOR GOVERNMENT USE ONLY: (IPD) 02
DIC: A31 DIST: ADV: FC: CS
Need Ship Date:00/00/0000 Original Required Delivery Date:03/20/2025
SPE2DP-26-T-4430 NSN/Part Number: 6505-01-707-4169 Quantity: 1 BX Purchase Request: 7017693912QTY: 1 Delivery: 5 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325411
New
DIBBS
PSYLLIUM HYDROPHILIC M
Solicitation # SPE2DP-26-T-4405
The contract is for the procurement of Psyllium Hydrophilic Mucilloid in 12-gram packets, each containing 25 mg of potassium and 5 mg of sodium, packaged in units of 30 packets per case. This product is regulated by the FDA and must be supplied with its manufacturer’s part number NDC37000-0740-87, sourced from Procter & Gamble Distributing LLC. The item has a non-extendable shelf life of 24 months and must comply with DLA’s technical and quality requirements as defined in the DLA Master List, with packaging and marking strictly governed by Medical Marking Standard No. 1, which supersedes all references to MIL-STD-129. Packaging must meet MIL-STD-2073-1E and DLA-specific packaging requirements, ensuring secure, commercial-grade containment capable of protecting contents during transit. Delivery is FOB destination with no tolerance for quantity variance, and items must be shipped within five days of contract award using the fastest traceable means—parcel post is prohibited. The delivery address is a Navy vessel in FPO AP 96675, with specific shipping and marking instructions governed by DLA’s logistics protocols. The NSN is 6505-01-719-3181, and the contract number is SPE2DP-26-T-4405, with an original required delivery date of August 4, 2026. All bids must include the supplier and manufacturer details for FDA referral through EBS prior to award.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 4 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325411
New
DIBBS
SUMATRIPTAN SUCCINATE
Solicitation # SPE2DP-26-T-4415
Sumatriptan Succinate Tablets, 100 mg, are supplied in a bottle of nine tablets and are indicated for the acute treatment of migraine with or without aura in adults. The product must be stored at controlled room temperature between 20 to 25°C (68 to 77°F) and protected from light, in compliance with USP standards. The item is regulated by the FDA and subject to strict shelf-life requirements: it has a non-extendable shelf life of 24 months as a Type I CODE M item, and must be marked according to the latest edition of Medical Marking Standard No. 1 and MIL-STD-129 for packaging and labeling. Packaging and palletization must adhere to DLA’s Packaging Requirements for Procurement and MIL-STD-2073-1E, with no tolerance for quantity variance. The contract specifies delivery FOB destination within 20 days, with inspection and acceptance occurring at the destination. The supplier is identified as MYLAN PHARMACEUTICALS INC with NDC 00378-5632-59, and the item is procured under NSN 6505-01-727-8704. Delivery is to a U.S. military address in APO AE 09094-3219, with freight originating from Ramstein, Germany. The solicitation number is SPE2DP-26-T-4415, with a required delivery date of August 4, 2026, and bid responses due by August 10, 2026. Technical and quality requirements are governed by the DLA Master List, and the contracting official must submit a referral through EBS for FDA product validation prior to award.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 4 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325411
New
DIBBS
CARD CASUALTY RESPO
Solicitation # SPE2DS-26-T-298R
The CARD CASUALTY RESPONSE DOCUMENTATION TOOL is a compact, durable card measuring 6.5 inches by 4 and 2/8 inches, constructed from card stock with a grommet and sealed in clear plastic for protection, accompanied by a 14-inch cable tie to securely fasten it to the patient. Designed for frontline responders, it captures essential data elements required for initial casualty treatment documentation. Each card includes a unique individual bar code identifier to ensure accurate tracking and record linkage. The unit of issue is singular, and the item is designated by NSN 6515-01-575-2772 with a procurement quantity of 8 units under purchase request 7017710965. Delivery is required within five days of award, with performance occurring in WaterVliet, New York, 12189-5000. The contract, issued under solicitation SPE2DS-26-T-298R, is subject to technical and quality requirements from the DLA Master List, with compliance dependent on the revision in effect at the solicitation or award date. It falls under NAICS code 325411 and is managed by the Department of Defense’s Medical Supply Chain MD Surg FSF. The item is classified as potentially containing covered defense information, and packaging must follow DLA procurement standards. Government identification must be removed from non-accepted supplies, and bidders are required to specify their source and part number. All submissions must be made prior to the response deadline of August 10, 2026, with the solicitation posted on August 2, 2026.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 4 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325411
New
DIBBS
HYDROCORTISONE CREA
Solicitation # SPE2DP-26-T-4438
The contract specifies the procurement of 10 units of Hydrocortisone Cream 2.5% in 1 oz tubes, manufactured by Sun Pharmaceutical Industries, Inc., with NDC number 10631-0407-01. Each unit must be packaged in compliance with the Medical Marking Standard No. 1 and MIL-STD-2073-1E, with all labeling and marking requirements strictly followed, superseding any reference to MIL-STD-129. The product is regulated by the FDA and requires a 24-month non-extendable shelf life, with storage conditions maintained at controlled room temperature between 20 to 25°C (68 to 77°F) and protected from freezing. Delivery is required FOB destination within five days of contract award, with no variance allowed in quantity, and inspection and acceptance occur at the delivery point. The shipment must be sent by the fastest traceable means, excluding parcel post, to Fort Stewart, Georgia, under the solicitation number SPE2DP-26-T-4438. Packaging must ensure safe transit via commercial carriers at the lowest cost, with each unit sealed and protected from damage. All technical and quality requirements are governed by the DLA Master List, and the contract incorporates specific DLA packaging directives including RP001 and RD003. The contract is issued under a federal procurement system with a unit of issue of EA and a total value of $10.00.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 4 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325411
New
DIBBS
PSYLLIUM HYDROPHILI
Solicitation # SPE2DP-26-T-4403
The contract is for Psyllium Hydrophilic Mucilloid in 12 gm packets, each containing 25 mg potassium and 5 mg sodium, sold in units of 30 packets per package, with a total quantity of 10 packages required. The product, identified by NSN 6505-01-719-3181 and manufacturer part number NDC37000-0740-87 from Procter & Gamble Distributing LLC, is regulated by the FDA and must comply with all applicable medical and packaging standards, including the Medical Marking Standard No. 1, which supersedes MIL-STD-129 for this item. The product has a non-extendable shelf life of 24 months under Type I (Code M) requirements, and all packaging must meet DLA’s commercial packaging and protection standards as outlined in MIL-STD-2073-1E and RP001, ensuring secure, carrier-acceptable delivery to the destination. Delivery is required FOB destination within 79 days of contract award, with no tolerance for quantity variance, and the item must be marked and packed strictly according to specified medical and defense logistics guidelines. The contract identifies the delivery point as APO AP 96260-5479, with the final destination at Camp Carroll, Korea, and the original required delivery date is December 17, 2025. Bidders must provide the exact source and part number being offered and are subject to FDA referral through EBS prior to award. All documentation and compliance are governed by the DLA Master List of Technical and Quality Requirements in effect on the solicitation issue date, and transport arrangements must follow DLAD Proc Notes C19 and C20. The solicitation, issued under contract number SPE2DP-26-T-4403, has a response deadline of August 10, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 4 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325411
New
International
Supply of Diabetic and Low-Sugar Nutritional ProductsThe contract involves the manufacture and delivery of specialized sugar-free and low-glycemic medical nutritionals designed specifically for diabetic patients in hospital settings across Jamaica. These products must meet stringent nutritional and medical standards to support glycemic control and overall patient health within institutional care environments. The supplier is expected to ensure consistent production quality, adherence to regulatory protocols, and reliable distribution to meet the ongoing needs of healthcare facilities under the South East Regional Health Authority. This subcontract is issued under the NAICS code 325411, indicating it pertains to pharmaceutical and medicine manufacturing, and is administered by the Government of Jamaica through its health authority. The solicitation was posted on July 30, 2026, and the performance location is tied to the health authority’s operational network, though specific delivery sites are not detailed. While the contract does not specify a set-aside designation or point of contact, interested parties must navigate the official ePPS portal linked in the notice to access full procurement details and submit proposals in compliance with government procurement guidelines.
South East Regional Health Authority

POSTED

3 days ago

DEADLINE

N/A
View Details
NAICS: 325411
New
International
Supply of High-Protein Nutritional SupplementsThe contract is for the supply of high-protein nutritional supplements designed to meet the therapeutic needs of malnourished individuals and those recovering from surgery, ensuring they receive essential protein-enriched medical foods to support recovery and overall health. The product must be formulated specifically for clinical use, delivering precise nutritional profiles to address deficiencies and promote healing in vulnerable patient populations under medical supervision. The agreement is structured as a subcontract and falls under the NAICS code 325411, indicating classification within pharmaceutical and pharmaceutical preparation manufacturing. The contracting authority is the South East Regional Health Authority under the Government of Jamaica, with the solicitation posted on July 30, 2026, and the supplies to be delivered to locations within Jamaica’s south eastern region. The contract does not involve a set-aside designation, and detailed performance location or point of contact information is not provided. All deliveries must align with medical standards for therapeutic nutrition, and the successful vendor will be expected to maintain consistent quality, regulatory compliance, and timely fulfillment to support ongoing patient care programs across the region. Access to further details is available through the official government e-procurement portal.
South East Regional Health Authority

POSTED

3 days ago

DEADLINE

N/A
View Details
NAICS: 325411
New
International
Supply of Pediatric Nutritional FormulasThe contract entails the supply of specialized infant and pediatric nutritional products designed to support growth and address specific medical conditions in children’s hospital settings. These include growth-support formulas and condition-specific medical nutritionals tailored for neonatal and pediatric patients, ensuring appropriate dietary intervention for those with unique nutritional needs due to illness, prematurity, or developmental challenges. The scope is focused exclusively on delivering high-quality, medically validated products to healthcare facilities under the jurisdiction of the South East Regional Health Authority in Jamaica. The agreement is structured as a subcontract and falls under the NAICS code 325411, indicating classification within pharmaceutical and medicine manufacturing. It was posted on July 30, 2026, and is administered by the Government of Jamaica through its regional health authority. While no specific place of performance or point of contact is detailed, the products are intended for use within children’s hospitals served by the authority, and all deliveries must meet stringent healthcare standards to ensure patient safety and efficacy. The contract does not specify a set-aside designation, and potential suppliers must comply with regulatory and quality requirements applicable to infant and pediatric medical nutritionals in Jamaica.
South East Regional Health Authority

POSTED

3 days ago

DEADLINE

N/A
View Details
NAICS: 325411
New
International
Supply of Adult Nutritional FormulasThe contract entails the manufacture and supply of enteral nutrition formulas, meal replacements, and vitamin-fortified beverages specifically formulated for adult patients across six hospitals under the South East Regional Health Authority in Jamaica. The products must meet clinical standards to support nutritional therapy and recovery in hospital settings, with delivery obligations spanning the entire network of designated facilities. The contracting entity operates under the Government of Jamaica, and the work is classified as a subcontract with a NAICS code of 325411, indicating the production of pharmaceutical and botanical products, including specialized nutritional formulations. The contract was posted on July 30, 2026, and performance is expected to occur within Jamaica, with no geographic restrictions beyond the specified hospitals. The procurement is not subject to a set-aside designation, and the supplier must ensure consistent quality, regulatory compliance, and timely distribution to meet ongoing patient care needs.
South East Regional Health Authority

POSTED

3 days ago

DEADLINE

N/A
View Details
NAICS: 325411
New
DIBBS
BENZOCAINE AND MENTHOL
Solicitation # SPE2DP-26-T-4388
The contract specifies the procurement of 6 packages of benzocaine 15 mg-menthol 10 mg lozenges, with the NDC78112-0017-46 and NSN 6505-01-706-1600, under solicitation SPE2DP-26-T-4388. The item is classified as a Type I (Code Q) medical product with a non-extendable shelf life of 36 months, and packaging must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Each unit must be sealed in a protective container and packed in commercial shipping containers that ensure safe, low-cost delivery to the designated destination, Ellsworth AFB, South Dakota. The order requires delivery within five days, with no variance permitted in quantity, and acceptance occurs at the destination point. All packaging, marking, and palletization must adhere to DLA’s packaging requirements, and the material must be shipped via traceable freight methods—parcel post is prohibited. The supplier, AmerisourceBergen Drug Corp, must meet technical and quality standards referenced in the DLA Master List, and all documentation and labeling must follow the latest applicable revisions as of the solicitation or award date. The point of contact for the contract is Vanesa M. Carbo Acevedo, and the original required delivery date is July 9, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

3 days ago

DEADLINE

in 3 days
View Details
NAICS: 325411
New
DIBBS
Supply of Electrochemiluminescence (ECL) Performance Qualification KitThe contract solicits the supply and delivery of a reagent-based medical kit designed for performance qualification of Electrochemiluminescence (ECL) instrumentation, specifically compatible with the MSD PR2 Model 1800. The kit includes ten plates and all necessary reagents to ensure accurate and reliable validation of the instrument’s operational parameters. This subcontract is part of the Department of Defense’s Medical Supply Chain initiative under the agency name MEDICAL SUPPLY CHAIN MD SURG FSF, with performance required at the APO location identified by zip code 96328-5225. The solicitation was posted on July 29, 2026, and responses are due by August 4, 2026, with a NAICS code of 325411 indicating the industry classification for pharmaceutical and medicine manufacturing. The purpose is to maintain the integrity and accuracy of diagnostic testing equipment used in military medical operations.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

4 days ago

DEADLINE

in 2 days
View Details
NAICS: 325411
New
DIBBS
NIRMATRELVIR AND RI
Solicitation # SPE2DP-26-T-4361
The contract is for the procurement of 50 boxes of Nirmatrelvir and Ritonavir tablets, marketed as Paxlovid, with each box containing 10 blister cards, each card housing three tablets—two 150 mg Nirmatrelvir and one 100 mg Ritonavir—providing a five-day supply of two daily doses per box. The item is designated by NSN 6505017227590 and manufacturer part number NDC00069-5321-30, supplied by Pfizer Inc. The contract requires delivery of all units within 20 calendar days of order receipt to the Navy Expeditionary Central Facility in Williamsburg, Virginia, under FOB Destination terms, meaning the contractor bears all transportation costs and risks until receipt at the destination. The product is regulated by the FDA and subject to strict shelf-life controls requiring a minimum 36-month non-extendable shelf life under RS020. Packaging and marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must ensure protection against damage through sealed unit packaging and commercial-grade shipping containers, with palletization conforming to DLA packaging requirements. Each unit must be labeled with NSN, lot number, expiration date, and contain a 2D Data Matrix barcode for automated logistics tracking. The contract is a firm-fixed-price procurement with no tolerance for quantity variance, and payment must be submitted electronically via WAWF. All offerings must include the manufacturer’s source and part number, and the contractor must comply with federal regulations regarding hazardous materials, cybersecurity safeguards, cybersecurity incident reporting, prohibition of covered telecommunications equipment, and prohibitions on hexavalent chromium and toxic material handling. Offerors must hold a valid UEI and CAGE code and affirm compliance with Equal Opportunity, Combating Trafficking in Persons, Employment Eligibility Verification, and Sustainable Products requirements. The solicitation closed on August 4, 2026, with award expected shortly thereafter under the DLA Automated Simplified Acquisition framework.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

4 days ago

DEADLINE

in 2 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 325412
New
DIBBS
ALUMINUM HYDROXIDE GEL
Solicitation # SPE2DP-26-T-4441
ALUMINUM HYDROXIDE GEL, USP, is procured under solicitation SPE2DP-26-T-4441 with a unit of issue as one bottle (1 BT or 16 OZ), requiring compliance with DLA’s Medical Marking Standard No. 1 and labeling per MMS No. 1A dated February 4, 2013, superseding MIL-STD-129. The product must have a mandatory 24-month shelf life, with no less than 21 months remaining from the date of manufacture to the date of government delivery. Packaging must meet commercial standards, ensuring each unit is sealed and protected against damage, and shipped in exterior containers suitable for safe transport via common carrier at the lowest cost to the destination specified in the contract. All items must be marked in accordance with DLA’s Medical Marking Standard, including NSN, manufacturer and CAGE code, date of manufacture, expiration date, contract number, and lot number. The item is regulated by the FDA, requiring referral via EBS to a product specialist before award, and must be accompanied by the manufacturer’s part number NDC00536-0091-85 from Watson Pharma Inc., with CAGE code 1DWF9. Delivery is FOB destination within 20 days, with zero variance in quantity and inspection and acceptance occurring at point of delivery. Packaging must conform to MIL-STD-2073-1E, and all technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements referenced in the document.
Pharmaceutical Preparation Manufacturing

POSTED

about 4 hours ago

DEADLINE

in 8 days
View Details
NAICS: 424210
New
DIBBS
SODIUM CHLORIDE INJECT
Solicitation # SPE2DP-26-T-4397
Sodium Chloride Injection USP 0.9% in 1000ml plastic bags, latex free, is being procured under solicitation SPE2DP-26-T-4397 with a unit of issue defined as one package of twelve units. The product must comply with strict technical and quality requirements as defined in the DLA Master List of Technical and Quality Requirements and must adhere to Medical Marking Standard No. 1, superseding all references to MIL-STD-129. Packaging must be commercial-grade, sealed, and designed to protect against damage and breakage, with exterior shipping containers ensuring safe and cost-effective delivery to the destination point. The item is regulated by the FDA and has a non-extendable shelf life of 30 months, with storage required at controlled room temperature between 20°C and 25°C, protection from excessive heat and freezing, and segregation from incompatible materials. The sole approved manufacturer is B. Braun Medical Inc with part number NDC00264-5802-00, though other vendors may submit bids under their respective part numbers. The contract specifies a firm quantity of twelve units per package, with zero variance permitted, and requires delivery within five days FOB destination to Carville, LA 70721. Inspection and acceptance occur at the delivery point. All markings, documentation, and compliance must align with current DLA standards, and buyers must refer specific bidder and manufacturer details to the DLA product specialist via EBS for confirmation prior to award.
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 4 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325412
New
DIBBS
HYDROGEN PEROXIDE TOPI
Solicitation # SPE2DP-26-T-4396
Hydrogen Peroxide Topical Solution, USP, is a 3% stabilized topical solution intended for external use only, with clear warnings against use in the eyes or over large body areas and a maximum usage duration of one week. Each unit is a 473-milliliter (16-fluid-ounce) bottle, requiring tight closure, storage at controlled room temperature, protection from freezing and excessive heat, and no shaking. Packaging and labeling must comply with Medical Marking Standard No. 1A dated February 4, 2013, superseding MIL-STD-129, and all units must be sealed in commercial containers suitable for transit and protected from damage. The product is regulated by the FDA and classified as a Type I (Code M) item with a non-extendable shelf life of 24 months. Suppliers must provide Safety Data Sheets (SDS) conforming to 29 C.F.R. 1910.1200 and Hazard Communication Standard (HCS) compliant labels as of June 1, 2015, and must train employees on these requirements. All packaging and shipping must meet commercial standards and ensure safe delivery at the lowest cost to the destination. The item is identified by NSN 6505-00-153-8480, with a purchase request number of 7017684184 and a quantity of 20 bottles. Delivery is FOB destination within 20 days, with zero variance allowed. Solicitation number SPE2DP-26-T-4396, posted August 2, 2026, requires response by August 10, 2026. Approved manufacturers include McKesson, Cardinal Health, and Medline Industries. The contract is administered by the Department of Defense’s Medical Supply Chain, with delivery to Pineville, LA, and point of contact Patrell Postell. All requisitions previously associated with DMLIIS Request ID 1721935 under ACC-L have been canceled without replacement, transitioning to ACCY.
Pharmaceutical Preparation Manufacturing

POSTED

about 4 hours ago

DEADLINE

in 8 days
View Details
NAICS: 456199
New
DIBBS
LUBRICANT, SURGICAL
Solicitation # SPE2DP-26-T-4417
The contract is for surgical lubricant, a sterile, latex-free, water-soluble jelly containing parabens, with each foil packet containing 2.7 grams and packaged in boxes of 144 packets as the unit of issue. The product must comply with strict technical and quality requirements outlined in the DLA Master List, and all packaging and marking must adhere to the Medical Marking Standard No. 1, which supersedes MIL-STD-129. The item has a non-extendable shelf life of 36 months and must be stored at 20°C to 25°C (68°F to 77°F). It is regulated by the FDA and classified as a TYPE I (CODE Q) item with specific shelf-life controls. The supplier, MEDLINE INDUSTRIES, LP, must provide the item under part number MDS032273H, and the NSN is 6505-01-626-5774. The contract requires delivery of one box within 20 days to a designated military destination, with FOB destination terms and zero variance permitted on quantity. All packaging must be commercial-grade, sealed, and designed for safe transit with minimal cost to ensure unharmed delivery. The item must be marked according to MMS No. 1, and transportation details are governed by DLAD procedural notes. The contract is issued under solicitation SPE2DP-26-T-4417 with a required delivery date of August 4, 2026, and the point of contact is Nicholas Quigley of the Department of Defense’s Medical Supply Chain.
All Other Health and Personal Care Retailers

POSTED

about 4 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325412
New
DIBBS
DIBUCAINE OINTMENT
Solicitation # SPE2DP-26-T-4418
Dibucaine Ointment USP is a topical pharmaceutical product containing 1 percent dibucaine as the active ingredient, formulated for rectal administration and external use only. It is supplied in a collapsible tube and includes a rectal applicator, with each unit of issue being a single package containing one ounce or 28 grams of ointment. The product must be stored at temperatures between 15 and 30 degrees Celsius (59 to 86 degrees Fahrenheit) and carries a non-extendable shelf life of 36 months, classified as a TYPE I (CODE Q) item. Packaging and marking must comply with the latest edition of the Medical Marking Standard No. 1 and MIL-STD-2073-1E, ensuring proper government logistics handling. The item is regulated by the FDA, and procurement requires a referral through EBS to verify compliance before award. This product is procured under solicitation SPE2DP-26-T-4418 with a required delivery within five days to Offutt AFB, zip 68113-1044, under FOB destination terms. Quantity is fixed at one package (PG) with zero variance allowed, and inspection and acceptance occur at the delivery point. The National Stock Number is 6505-00-299-9535, and the NDC code is 00536-1211-95. The supplier is The Harvard Drug Group, L.L.C., and the procurement is managed by the Department of Defense’s Medical Supply Chain Pharmacy FSA. Contract data specifies a response deadline of August 10, 2026, with technical and quality requirements governed by the DLA Master List of Technical and Quality Requirements. Covered Defense Information may apply under RD003, and removal of government identification from non-accepted supplies is required per RQ011.
Pharmaceutical Preparation Manufacturing

POSTED

about 4 hours ago

DEADLINE

in 8 days
View Details
NAICS: 423450
New
DIBBS
OMEPRAZOLE EXTENDED-RE
Solicitation # SPE2DP-26-T-4416
The contract specifies the procurement of 20 mg extended-release omeprazole capsules in 90-count bottles, identified by NSN 6505016247068 and manufacturer part number NDC00781-2868-92 from Sandoz Inc. Each unit must be packaged in commercial-grade sealed containers that protect against damage, with outer shipping containers ensuring safe, low-cost delivery to listed government destinations under FOB destination terms. A minimum of 21 months of shelf life must remain at delivery, with a total shelf life of 24 months that is non-extendable. All packaging, labeling, and marking must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and palletization must adhere to DLA Packaging Requirements for Procurement. The product is regulated by the FDA and requires pre-award referral for confirmation. Shipments must use traceable transportation methods and explicitly prohibit parcel post. Deliveries are scheduled across multiple CLINs totaling 57 units, with a mandatory delivery window of five days and no variance allowed in quantity. All items must be labeled and stored at controlled room temperature, with packaging materials and methods governed by DLA’s Master List of Technical and Quality Requirements, which take precedence over ASTM D3951. Shipping addresses include military facilities at Fort Bragg, North Carolina, and APO AP, with required point-of-contact and program tracking information provided for government use.
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

about 4 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325412
New
DIBBS
PETROLATUM, WHITE
Solicitation # SPE2DP-26-T-4447
The contract specifies the procurement of Petrolatum, White, USP, with a unit of issue of 1 TU equaling 28 mg, and a total quantity of 1 TU required. The item has a non-extendable shelf life of 36 months and must be packaged in accordance with the Medical Marking Standard No. 1, which supersedes MIL-STD-129, and all packaging must ensure protection against damage and compliance with commercial shipping standards for safe delivery to the destination. The material is not classified as hazardous under FED-STD-313 and must be commercially packaged per ASTM D3951, though any conflicting requirements from the DLA Master List of Technical and Quality Requirements take precedence. Labeling and marking of all containers must strictly follow the latest edition of Medical Marking Standard No. 1, and packaging must be palletized per RP001, using the designated unit pack configuration and ensuring the lowest freight cost to the specified delivery point. Delivery is required within five days of award, FOB destination, with zero variance allowed in quantity, and inspection and acceptance occur upon arrival. The item is to be shipped by the fastest traceable means, excluding parcel post, to the government address in Morrisville, NC, with explicit instructions to avoid using outdated or non-compliant marking systems. The solicitation is issued under contract SPE2DP-26-T-4447, with a required delivery date of August 4, 2026, and the item is identified by NSN 6505-00-254-5527 and NDC 53329-0068-01, supplied by Medline Industries, LP.
Pharmaceutical Preparation Manufacturing

POSTED

about 4 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325412
New
DIBBS
OMEPRAZOLE EXTENDED-RE
Solicitation # SPE2DP-26-T-4402
Omeprazole extended-release capsules, 20 mg in 30-count units, are procured under solicitation SPE2DP-26-T-4402 for government use with a total requirement of 23,000 units across multiple contract line items. Each unit must be packaged in sealed containers that protect against damage and shipped in commercial exterior containers to ensure safe, low-cost delivery to designated government destinations. The product must be stored at controlled room temperature between 20 and 25 degrees Celsius and carries a non-extendable shelf life of 18 months. All packaging and labeling must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and conform to DLA packaging requirements including palletization and hazardous material handling per Fed-Std-313 and ASTM D3951 where applicable. The item is regulated by the FDA and requires supplier verification through EBS referral. Shipments must be sent by traceable means only, excluding parcel post, and deliveries are required FOB destination within five days of ship date. The original required delivery date for all orders is no later than August 4, 2026, with one contract line due by July 30, 2026. The contract includes multiple delivery addresses across Fort Lewis, Washington, and Watervliet Arsenal, New York, with strict adherence to unit of issue and quantity per unit pack specifications. The sole source manufacturers listed include Astra Pharmaceutical Products Inc, Sandoz Inc, Amerisource Health Services LLC, and Golden State Medical Supply Inc, with NDC numbers specified for each.
Pharmaceutical Preparation Manufacturing

POSTED

about 4 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325412
New
DIBBS
PERMETHRIN CREAM RINSE
Solicitation # SPE2DP-26-T-4404
Permethrin Cream Rinse is a 1% w/v topical pharmaceutical product packaged in a 2 fluid ounce plastic squeeze bottle, each unit including a comb for application. The product has a 24-month shelf life, with a mandatory minimum of 21 months remaining at the time of receipt by the first government activity. It is regulated by the FDA and subject to strict medical acquisition standards, including commercial packaging requirements that ensure the unit is sealed and protected from damage, and shipments are placed in suitable exterior containers for safe transport at the lowest carrier rate. All items must be marked in compliance with Medical Marking Standard No. 1, replacing all references to MIL-STD-129. The product is hazardous and requires compliance with Federal Standard No. 313-E, mandating submission of current Safety Data Sheets (SDS) formatted per 29 C.F.R. 1910.1200 and appropriate Hazard Communication Standard labels prior to award. Each shipment must include a physical copy of the SDS, and suppliers must submit these documents to DLA.MSDS@DLA.MIL with a completed cover sheet. Packaging must meet 49 CFR and ICAO regulations for hazardous materials. Technical and quality requirements are governed by the DLA Master List, and the procurement is subject to Hazard Communication Standard updates. The NSN is 6505-01-256-4972, and the solicitation requires delivery of five units within five days of award, with the contract issued under SPE2DP-26-T-4404 by the Department of Defense, Medical Supply Chain Pharm FSA.
Pharmaceutical Preparation Manufacturing

POSTED

about 4 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325412
New
DIBBS
ALBUTEROL SULFATE INHA
Solicitation # SPE2DP-26-T-4437
Albuterol Sulfate Inhalation Aerosol with HFA is a prescription-only medication for oral inhalation, with each actuation delivering 108 micrograms of albuterol sulfate equivalent to 90 micrograms of albuterol base, supplied in an 8.5-gram canister containing 200 metered doses. The product must be stored at room temperature between 59°F and 77°F, protected from extreme heat or cold, and must not be punctured, exposed to flames, or stored near heat sources, as temperatures above 120°F may cause the canister to burst. It is subject to a non-extendable 24-month shelf life and must be labeled with the National Stock Number, manufacturer name, date of manufacture, expiration date, contract number, and lot number. All packaging and marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must be shipped in sealed commercial unit containers and approved shipping containers suitable for safe transport at the lowest rate to the delivery point specified. The product is regulated by the FDA and requires submission of Safety Data Sheets and Hazard Communication Standard-compliant labels as mandated by OSHA’s Globally Harmonized System, with supplier training on these requirements. Delivery is FOB destination within five days, with zero tolerance for quantity variance, and inspection and acceptance occur at the delivery point. The contract is issued under solicitation SPE2DP-26-T-4437 for a quantity of 12 units, with the National Stock Number 6505015436562, and references applicable DLA technical and quality requirements contained in the DLA Master List.
Pharmaceutical Preparation Manufacturing

POSTED

about 4 hours ago

DEADLINE

in 8 days
View Details